On May 1, 2024, growth investor and executive insights company GrowthCap named McKesson Ventures’ Managing Director Dave Schulte as one of its Top 25 Healthcare Investors of 2024. The list, published annually and founded in 2021, seeks to acknowledge individuals who have made astounding achievements in the field of healthcare investing, and are chosen for their individual abilities to “provide unique strategic and/or operational value to the companies they invest in.”
Schulte expressed his excitement in an interview with GrowthCap for the announcement, stating, “This recognition underscores the success of our fund and appreciation for the value of partnering with McKesson Ventures. I am proud of the entrepreneurs we have supported, the team we have built, and the impact that we have had on healthcare innovation.” When asked about his thoughts on the healthcare investment landscape as a whole, Schulte said, “We have never been more optimistic about the potential for entrepreneurial companies to advance health outcomes and our ability to help them succeed.”
Read the full list of investors here.
See related materials: